NAD^+^ synthetase(glutamine-hydrolysing)
RxNorm 98345
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 98345 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: NAD^+^ synthetase(glutamine-hydrolysing).
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
NAD^+^ synthase (glutamine-hydrolysing)
(Atom ID: 3800390)
SY
Synonym (SY):
NAD^+^ synthetase(glutamine-hydrolysing)
(Atom ID: 3800392)
SY
Synonym (SY):
Nicotinamide adenine dinucleotide ^+^ synthase (glutamine-hydrolysing)
(Atom ID: 5940151)
FN